Suchergebnisse

International audience ; The antiAtlas of Borders is an experimentation at the crossroads of research, art and practice. It was launched in 2011 at the Mediterranean Institute of Advanced Studies (Aix Marseille University), and has been co-produced by the Higher School of Art (Aix en Provence), PACTE laboratory (University of Grenoble-CNRS), Isabelle Arvers and La compagnie. Since then, it has gathered researchers (social and hard scientists), artists (web artists, tactical geographers, hackers, filmmakers, etc.) and professionals (customs, industry, military, etc.). The encounter of people coming from these different fields of knowledge and practice aims to create a radical shift of perspective in the way we apprehend both 21 st century borders and the boundaries separating fields of knowledge, art and practice.

International audience ; The antiAtlas of Borders is an experimentation at the crossroads of research, art and practice. It was launched in 2011 at the Mediterranean Institute of Advanced Studies (Aix Marseille University), and has been co-produced by the Higher School of Art (Aix en Provence), PACTE laboratory (University of Grenoble-CNRS), Isabelle Arvers and La compagnie. Since then, it has gathered researchers (social and hard scientists), artists (web artists, tactical geographers, hackers, filmmakers, etc.) and professionals (customs, industry, military, etc.). The encounter of people coming from these different fields of knowledge and practice aims to create a radical shift of perspective in the way we apprehend both 21 st century borders and the boundaries separating fields of knowledge, art and practice.

International audience The antiAtlas of Borders is an experimentation at the crossroads of research, art and practice. It was launched in 2011 at the Mediterranean Institute of Advanced Studies (Aix Marseille University), and has been co-produced by the Higher School of Art (Aix en Provence), PACTE laboratory (University of Grenoble-CNRS), Isabelle Arvers and La compagnie. Since then, it has gathered researchers (social and hard scientists), artists (web artists, tactical geographers, hackers, filmmakers, etc.) and professionals (customs, industry, military, etc.). The encounter of people coming from these different fields of knowledge and practice aims to create a radical shift of perspective in the way we apprehend both 21 st century borders and the boundaries separating fields of knowledge, art and practice.

BACKGROUND: Invasive infections caused by Staphylococcus aureus have high clinical and epidemiological relevance. It is therefore important to monitor the S. aureus trends using suitable methods. AIM: The study aimed to describe the trends of bloodstream infections (BSI) caused by meticillin-resistant S. aureus (MRSA) and meticillin-susceptible S. aureus (MSSA) in the European Union (EU) and the European Economic Area (EEA). METHODS: Annual data on S. aureus BSI from 2005 to 2018 were obtained from the European Antimicrobial Resistance Surveillance Network (EARS-Net). Trends of BSI were assessed at the EU/EEA level by adjusting for blood culture set rate (number of blood culture sets per 1,000 days of hospitalisation) and stratification by patient characteristics. RESULTS: Considering a fixed cohort of laboratories consistently reporting data over the entire study period, MRSA percentages among S. aureus BSI decreased from 30.2% in 2005 to 16.3% in 2018. Concurrently, the total number of BSI caused by S. aureus increased by 57%, MSSA BSI increased by 84% and MRSA BSI decreased by 31%. All these trends were statistically significant (p < 0.001). CONCLUSIONS: The results indicate an increasing health burden of MSSA BSI in the EU/EEA despite a significant decrease in the MRSA percentage. These findings highlight the importance of monitoring antimicrobial resistance trends by assessing not only resistance percentages but also the incidence of infections. Further research is needed on the factors associated with the observed trends and on their attributable risk.

Burden of AMR Collaborative Group:National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal (Prof M Caniça PhD, Vera Manageiro PhD) ; Free PMC Article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300481/ ; Background: Infections due to antibiotic-resistant bacteria are threatening modern health care. However, estimating their incidence, complications, and attributable mortality is challenging. We aimed to estimate the burden of infections caused by antibiotic-resistant bacteria of public health concern in countries of the EU and European Economic Area (EEA) in 2015, measured in number of cases, attributable deaths, and disability-adjusted life-years (DALYs). Methods: We estimated the incidence of infections with 16 antibiotic resistance–bacterium combinations from European Antimicrobial Resistance Surveillance Network (EARS-Net) 2015 data that was country-corrected for population coverage. We multiplied the number of bloodstream infections (BSIs) by a conversion factor derived from the European Centre for Disease Prevention and Control point prevalence survey of health-care-associated infections in European acute care hospitals in 2011–12 to estimate the number of non-BSIs. We developed disease outcome models for five types of infection on the basis of systematic reviews of the literature. Findings: From EARS-Net data collected between Jan 1, 2015, and Dec 31, 2015, we estimated 671 689 (95% uncertainty interval [UI] 583 148–763 966) infections with antibiotic-resistant bacteria, of which 63·5% (426 277 of 671 689) were associated with health care. These infections accounted for an estimated 33 110 (28 480–38 430) attributable deaths and 874 541 (768 837–989 068) DALYs. The burden for the EU and EEA was highest in infants (aged <1 year) and people aged 65 years or older, had increased since 2007, and was highest in Italy and Greece. Interpretation: Our results present the health burden of five types of infection with antibiotic-resistant bacteria expressed, for the first time, in DALYs. The estimated burden of infections with antibiotic-resistant bacteria in the EU and EEA is substantial compared with that of other infectious diseases, and has increased since 2007. Our burden estimates provide useful information for public health decision-makers prioritising interventions for infectious diseases. ; European Centre for Disease Prevention and Control ; info:eu-repo/semantics/publishedVersion